Your browser doesn't support javascript.
loading
An Update on the Pathogenesis of Fascioliasis: What Do We Know?
Tanabe, Melinda B; Caravedo, Maria A; Clinton White, A; Cabada, Miguel M.
Affiliation
  • Tanabe MB; Division of Infectious Disease, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA.
  • Caravedo MA; Division of Infectious Disease, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA.
  • Clinton White A; Division of Infectious Disease, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA.
  • Cabada MM; Cusco Branch - Alexander von Humboldt Tropical Medicine Institute, Universidad Peruana Cayetano Heredia, Cusco, Peru.
Res Rep Trop Med ; 15: 13-24, 2024.
Article de En | MEDLINE | ID: mdl-38371362
ABSTRACT
Fasciola hepatica is a trematode parasite distributed worldwide. It is known to cause disease in mammals, producing significant economic loses to livestock industry and burden to human health. After ingestion, the parasites migrate through the liver and mature in the bile ducts. A better understanding of the parasite's immunopathogenesis would help to develop efficacious therapeutics and vaccines. Currently, much of our knowledge comes from in vitro and in vivo studies in animal models. Relatively little is known about the host-parasite interactions in humans. Here, we provide a narrative review of what is currently know about the pathogenesis and host immune responses to F. hepatica summarizing the evidence available from the multiple hosts that this parasite infects.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Res Rep Trop Med Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Res Rep Trop Med Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique